These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 33341043)
1. Catestatin peptide of chromogranin A as a potential new target for several risk factors management in the course of metabolic syndrome. Bourebaba Y; Mularczyk M; Marycz K; Bourebaba L Biomed Pharmacother; 2021 Feb; 134():111113. PubMed ID: 33341043 [TBL] [Abstract][Full Text] [Related]
3. Development of a pharmacophore model for the catecholamine release-inhibitory peptide catestatin: virtual screening and functional testing identify novel small molecule therapeutics of hypertension. Tsigelny IF; Kouznetsova VL; Biswas N; Mahata SK; O'Connor DT Bioorg Med Chem; 2013 Sep; 21(18):5855-69. PubMed ID: 23916146 [TBL] [Abstract][Full Text] [Related]
4. Plasma catestatin levels are related to metabolic parameters in patients with essential hypertension and type 2 diabetes mellitus. Pankova O; Korzh O Heart Vessels; 2024 Feb; 39(2):144-159. PubMed ID: 37758851 [TBL] [Abstract][Full Text] [Related]
5. Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity. Bandyopadhyay GK; Mahata SK Front Endocrinol (Lausanne); 2017; 8():20. PubMed ID: 28228748 [TBL] [Abstract][Full Text] [Related]
6. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome. Ferdinand KC J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832 [TBL] [Abstract][Full Text] [Related]
7. Catestatin: A Master Regulator of Cardiovascular Functions. Mahata SK; Kiranmayi M; Mahapatra NR Curr Med Chem; 2018; 25(11):1352-1374. PubMed ID: 28443506 [TBL] [Abstract][Full Text] [Related]
8. Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure. Mahapatra NR Cardiovasc Res; 2008 Dec; 80(3):330-8. PubMed ID: 18541522 [TBL] [Abstract][Full Text] [Related]
10. Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification. Friese RS; Gayen JR; Mahapatra NR; Schmid-Schönbein GW; O'Connor DT; Mahata SK Physiol Genomics; 2010 Feb; 40(3):195-207. PubMed ID: 19952279 [TBL] [Abstract][Full Text] [Related]
11. Management of hypertension in children and adolescents with the metabolic syndrome. Puri M; Flynn JT J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805 [TBL] [Abstract][Full Text] [Related]
12. Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo. Fung MM; Salem RM; Mehtani P; Thomas B; Lu CF; Perez B; Rao F; Stridsberg M; Ziegler MG; Mahata SK; O'Connor DT Clin Exp Hypertens; 2010; 32(5):278-87. PubMed ID: 20662728 [TBL] [Abstract][Full Text] [Related]
13. Catestatin Inhibits Obesity-Induced Macrophage Infiltration and Inflammation in the Liver and Suppresses Hepatic Glucose Production, Leading to Improved Insulin Sensitivity. Ying W; Mahata S; Bandyopadhyay GK; Zhou Z; Wollam J; Vu J; Mayoral R; Chi NW; Webster NJG; Corti A; Mahata SK Diabetes; 2018 May; 67(5):841-848. PubMed ID: 29432123 [TBL] [Abstract][Full Text] [Related]
14. Egg and Soy-Derived Peptides and Hydrolysates: A Review of Their Physiological Actions against Diabetes and Obesity. de Campos Zani SC; Wu J; Chan CB Nutrients; 2018 Apr; 10(5):. PubMed ID: 29710777 [TBL] [Abstract][Full Text] [Related]
15. Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse. Gayen JR; Gu Y; O'Connor DT; Mahata SK Endocrinology; 2009 Nov; 150(11):5027-35. PubMed ID: 19819970 [TBL] [Abstract][Full Text] [Related]
16. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Ihm SH; Jang SW; Kim OR; Chang K; Oak MH; Lee JO; Lim DY; Kim JH Atherosclerosis; 2012 Oct; 224(2):377-83. PubMed ID: 22877868 [TBL] [Abstract][Full Text] [Related]
17. A common genetic variant of the chromogranin A-derived peptide catestatin is associated with atherogenesis and hypertension in a Japanese population. Choi Y; Miura M; Nakata Y; Sugasawa T; Nissato S; Otsuki T; Sugawara J; Iemitsu M; Kawakami Y; Shimano H; Iijima Y; Tanaka K; Kuno S; Allu PK; Mahapatra NR; Maeda S; Takekoshi K Endocr J; 2015; 62(9):797-804. PubMed ID: 26211667 [TBL] [Abstract][Full Text] [Related]
18. Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384)). Biswas N; Curello E; O'Connor DT; Mahata SK Cell Tissue Res; 2010 Dec; 342(3):353-61. PubMed ID: 21052719 [TBL] [Abstract][Full Text] [Related]
19. Serum catestatin concentrations are decreased in obese children and adolescents. Simunovic M; Supe-Domic D; Karin Z; Degoricija M; Paradzik M; Bozic J; Unic I; Skrabic V Pediatr Diabetes; 2019 Aug; 20(5):549-555. PubMed ID: 30714297 [TBL] [Abstract][Full Text] [Related]
20. Perspectives on the Potential Benefits of Antihypertensive Peptides towards Metabolic Syndrome. Jahandideh F; Wu J Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]